,,ii #aahth ,,congress #ast ,session ,s4 #aabh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #cj1 #bjbc,ms4 ,hassan 7for herself and ,mr4 ,braun7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to establish special rules relating to information provided with respect to drug applications concerning method of use patents4 #a4 ,short title ,this ,act may be cited as the ,ensuring ,access to ,generic ,medications ,act4 #b4 ,special rules relating to method of use patents ,section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 is amended by adding at the end the following3 7z7 ,cause of action relating to drug use codes 7#a7 ,in general ,in the case of an application under subsection 7b77#b7 or 7j7 of this section or section #cea7k7 of the ,public ,health ,service ,act with respect to which the applicant seeking approval includes in the application a statement that a patent claiming a method of use does not claim a use for the drug that is the subject of such application1 as described in subsection 7b77#b77;,b7 or 7j77#b77;,a77viii71 or in the case of an application under such section #cea7k71 as otherwise required by the ,secretary1 the sponsor of the application under subsection 7b77#b7 or 7j7 or such section #cea7k7 described in paragraph 7#b7 may file a civil action in an appropriate district court of the ,united ,states against the holder of the approved application for the applicable reference drug or reference product seeking a court order requiring the holder to correct or delete information relating to a use code submitted by the holder of the reference drug or reference product with respect to such patent claiming a method of use1 on the ground that such use code-- 7,a7 does not correspond to a patent that claims the reference drug or reference product for which the application was approved2 7,b7 does not correspond to a patent that claims an approved method of using the reference drug or reference product2 or 7,c7 is overly broad or otherwise inaccurate or inappropriate4 7#b7 ,rule of construction ,nothing in this subsection shall be construed to affect the application of subsection 7j77#e77;,c77ii74 7#c7 ,definition ,for purposes of paragraph 7#a71 the term use code means the information relating to a patent claiming a method of using a drug that is approved under section #eje of this ,act or under section #cea of the ,public ,health ,service ,act1 as applicable1 based upon information submitted by the drug sponsor or holder of the approved application or licensure pursuant to section #cad4ec7;c77#b77;ii77,p77#c7 of title #ba1 ,code of ,federal ,regulations 7or any successor regulations74 4